Quote | PMV Pharmaceuticals Inc. (NASDAQ:PMVP)
Last: | $1.50 |
---|---|
Change Percent: | 0.0% |
Open: | $1.56 |
Close: | $1.50 |
High: | $1.56 |
Low: | $1.48 |
Volume: | 386,837 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | PMV Pharmaceuticals Inc. (NASDAQ:PMVP)
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Off...
BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOn...
Message Board Posts | PMV Pharmaceuticals Inc. (NASDAQ:PMVP)
Subject | By | Source | When |
---|---|---|---|
2022 American Society of Clinical Oncology (ASCO) Annual Meeting | crudeoil24 | investorshub | 05/27/2022 12:10:26 AM |
JUNE 7 > Updated data from ongoing Phase | crudeoil24 | investorshub | 05/27/2022 12:08:55 AM |
PMV Pharma Shares Rise 17%; Company to Present | crudeoil24 | investorshub | 05/26/2022 11:43:46 PM |
PMV Pharmaceuticals, Inc. is a precision oncology company, | crudeoil24 | investorshub | 05/26/2022 11:42:23 PM |
News, Short Squeeze, Breakout and More Instantly...
PMV Pharmaceuticals Inc. Company Name:
PMVP Stock Symbol:
NASDAQ Market:
PMV Pharmaceuticals Inc. Website:
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Off...
BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOn...
2024-05-13 08:30:02 ET Craig-Hallum analyst issues BUY recommendation for PMVP on May 13, 2024 07:30AM ET. PMVP was trading at $2.04 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy recommendations...